InflaRx (IFRX) Revenue (2023 - 2026)
Powered by 
Analysis
InflaRx (IFRX) Revenue (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 24.40 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 17.40 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 18.09 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 16.58 Bn |
| 10 | InflaRx | 85.79 Mn | -160.38 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 27,414.65 |
| Jun 30, 2026 | 45,834.25 |
| Dec 31, 2025 | -39,497.16 |
| Sep 30, 2025 | 27,858.58 |
| Jun 30, 2025 | 44,635.43 |
| Mar 31, 2025 | 37,906.76 |
| Dec 31, 2024 | -452.02 |
| Sep 30, 2024 | 135,980.44 |
| Jun 30, 2024 | 6,845.77 |
| Mar 31, 2024 | 39,149.22 |
| Dec 31, 2023 | 2,459.60 |
| Sep 30, 2023 | 66,189.57 |
| Jun 30, 2023 | -456.26 |
API Access
InflaRx Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=IFRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "IFRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=IFRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();